Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Nakayama H, Nakazato T, Takahata A, Sato E, Kawakami M, Okada K, Abe T, Hayashi T, Toyama K, Senpuku Y, Nakagawa M, Takano M, Tanaka K, Osada Y, Watanabe J, Yamamoto K, Sekiguchi Y, Oshikawa G, Kimura Y, Tokuhira M, Suzuki K, Ikezoe T, Iriyama N, Miura K, Kumagai T, Toyota S, Mori T

Open source

DOI: 10.1111/bjh.70810
Published: 2026 Sep 3
Container: British journal of haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70810,
  title = {Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.},
  author = {Nakayama H and Nakazato T and Takahata A and Sato E and Kawakami M and Okada K and Abe T and Hayashi T and Toyama K and Senpuku Y and Nakagawa M and Takano M and Tanaka K and Osada Y and Watanabe J and Yamamoto K and Sekiguchi Y and Oshikawa G and Kimura Y and Tokuhira M and Suzuki K and Ikezoe T and Iriyama N and Miura K and Kumagai T and Toyota S and Mori T},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70810},
  url = {https://doi.org/10.1111/bjh.70810}
}

RIS

TY  - JOUR
TI  - Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.
AU  - Nakayama H
AU  - Nakazato T
AU  - Takahata A
AU  - Sato E
AU  - Kawakami M
AU  - Okada K
AU  - Abe T
AU  - Hayashi T
AU  - Toyama K
AU  - Senpuku Y
AU  - Nakagawa M
AU  - Takano M
AU  - Tanaka K
AU  - Osada Y
AU  - Watanabe J
AU  - Yamamoto K
AU  - Sekiguchi Y
AU  - Oshikawa G
AU  - Kimura Y
AU  - Tokuhira M
AU  - Suzuki K
AU  - Ikezoe T
AU  - Iriyama N
AU  - Miura K
AU  - Kumagai T
AU  - Toyota S
AU  - Mori T
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70810
UR  - https://doi.org/10.1111/bjh.70810
ER  -

APA

H, N., T, N., A, T., E, S., M, K., K, O., T, A., T, H., K, T., Y, S., M, N., M, T., K, T., Y, O., J, W., K, Y., Y, S., G, O., Y, K., M, T., K, S., T, I., N, I., K, M., T, K., S, T., & T, M. (2026). Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.. British journal of haematology. https://doi.org/10.1111/bjh.70810

Source records

pubmed · retrieved 2026-09-25T04:49:04.731Z